Vestal Point Capital as of Sept. 30, 2024
Portfolio Holdings for Vestal Point Capital
Vestal Point Capital holds 69 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Insmed Com Par $.01 (INSM) | 8.9 | $117M | 1.6M | 73.00 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 7.6 | $100M | 900k | 111.41 | |
| Cytokinetics Com New (CYTK) | 6.0 | $79M | 1.5M | 52.80 | |
| Inari Medical Ord | 4.8 | $64M | 1.6M | 41.24 | |
| Arcellx Common Stock (ACLX) | 4.3 | $56M | 675k | 83.51 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 3.8 | $51M | 1.2M | 43.89 | |
| Kalvista Pharmaceuticals (KALV) | 3.5 | $46M | 4.0M | 11.58 | |
| Astria Therapeutics (ATXS) | 3.3 | $44M | 4.0M | 11.01 | |
| Immatics NV SHS (IMTX) | 3.2 | $43M | 3.8M | 11.41 | |
| Ultragenyx Pharmaceutical (RARE) | 3.2 | $42M | 750k | 55.55 | |
| Ascendis Pharma A/S Sponsored Adr (ASND) | 2.8 | $37M | 250k | 149.31 | |
| Soleno Therapeutics (SLNO) | 2.8 | $36M | 720k | 50.49 | |
| Day One Biopharmaceuticals I (DAWN) | 2.6 | $35M | 2.5M | 13.93 | |
| Savara (SVRA) | 2.6 | $34M | 8.1M | 4.24 | |
| Agios Pharmaceuticals (AGIO) | 2.6 | $34M | 760k | 44.43 | |
| Xenon Pharmaceuticals (XENE) | 2.5 | $33M | 825k | 39.37 | |
| BioMarin Pharmaceutical (BMRN) | 2.1 | $28M | 400k | 70.29 | |
| Avadel Pharmaceuticals Com Shs Put Option (AVDL) | 2.0 | $26M | 2.0M | 13.12 | |
| Biohaven Call Option (BHVN) | 1.9 | $25M | 500k | 49.97 | |
| uniQure NV SHS (QURE) | 1.8 | $23M | 4.8M | 4.93 | |
| Janux Therapeutics (JANX) | 1.7 | $22M | 485k | 45.43 | |
| Black Diamond Therapeutics (BDTX) | 1.7 | $22M | 5.0M | 4.35 | |
| Solid Biosciences Com New (SLDB) | 1.5 | $20M | 2.8M | 6.97 | |
| Edwards Lifesciences (EW) | 1.4 | $18M | 275k | 65.99 | |
| Gilead Sciences (GILD) | 1.3 | $17M | 200k | 83.84 | |
| Liquidia Corp Com New (LQDA) | 1.1 | $15M | 1.5M | 10.00 | |
| Agilent Technologies Inc C ommon (A) | 1.1 | $15M | 100k | 148.48 | |
| Bristol Myers Squibb (BMY) | 1.0 | $13M | 250k | 51.74 | |
| GSK Sponsored Adr (GSK) | 0.9 | $12M | 300k | 40.88 | |
| Bicara Therapeutics (BCAX) | 0.8 | $11M | 425k | 25.47 | |
| Dianthus Therapeutics (DNTH) | 0.8 | $11M | 395k | 27.38 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.8 | $11M | 205k | 51.10 | |
| Iteos Therapeutics | 0.8 | $11M | 1.0M | 10.21 | |
| Applied Therapeutics (APLT) | 0.7 | $9.7M | 1.1M | 8.50 | |
| Nurix Therapeutics (NRIX) | 0.7 | $9.5M | 425k | 22.47 | |
| Sanofi SA Sponsored Adr (SNY) | 0.7 | $8.6M | 150k | 57.63 | |
| Bruker Corporation (BRKR) | 0.7 | $8.6M | 125k | 69.06 | |
| Apogee Therapeutics (APGE) | 0.6 | $8.0M | 137k | 58.74 | |
| Zymeworks Del (ZYME) | 0.6 | $7.7M | 615k | 12.55 | |
| Lexeo Therapeutics (LXEO) | 0.6 | $7.7M | 850k | 9.04 | |
| Tarsus Pharmaceuticals (TARS) | 0.6 | $7.6M | 230k | 32.89 | |
| Alto Neuroscience Com Shs (ANRO) | 0.6 | $7.4M | 650k | 11.44 | |
| Becton, Dickinson and (BDX) | 0.5 | $7.2M | 30k | 241.10 | |
| Madrigal Pharmaceuticals (MDGL) | 0.5 | $6.4M | 30k | 212.22 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 0.5 | $6.1M | 125k | 48.73 | |
| Fate Therapeutics (FATE) | 0.4 | $5.9M | 1.7M | 3.50 | |
| Galapagos NV Spon Adr (GLPG) | 0.4 | $5.2M | 180k | 28.79 | |
| Urogen Pharma (URGN) | 0.4 | $5.1M | 400k | 12.70 | |
| Monte Rosa Therapeutics (GLUE) | 0.4 | $4.9M | 930k | 5.30 | |
| Geron Corporation (GERN) | 0.4 | $4.8M | 1.1M | 4.54 | |
| Passage Bio | 0.3 | $4.3M | 6.1M | 0.70 | |
| Allogene Therapeutics (ALLO) | 0.3 | $4.2M | 1.5M | 2.80 | |
| Prime Medicine (PRME) | 0.3 | $4.1M | 1.1M | 3.87 | |
| Ventyx Biosciences (VTYX) | 0.3 | $3.8M | 1.7M | 2.18 | |
| Zevra Therapeutics Com New (ZVRA) | 0.3 | $3.6M | 525k | 6.94 | |
| Ardelyx (ARDX) | 0.3 | $3.4M | 500k | 6.89 | |
| Ptc Therapeutics I (PTCT) | 0.2 | $3.0M | 80k | 37.10 | |
| Penumbra (PEN) | 0.2 | $2.9M | 15k | 194.31 | |
| Voyager Therapeutics (VYGR) | 0.2 | $2.9M | 490k | 5.85 | |
| Macrogenics (MGNX) | 0.2 | $2.7M | 830k | 3.29 | |
| Verve Therapeutics (VERV) | 0.2 | $2.5M | 525k | 4.84 | |
| Intra Cellular Therapies (ITCI) | 0.2 | $2.2M | 30k | 73.17 | |
| Establishment Labs Holdings Ord (ESTA) | 0.1 | $1.7M | 40k | 43.27 | |
| Relmada Therapeutics (RLMD) | 0.1 | $1.6M | 490k | 3.24 | |
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.1 | $1.5M | 1.5M | 1.02 | |
| Reneo Pharmaceuticals (RPHM) | 0.1 | $1.4M | 799k | 1.70 | |
| Chimerix (CMRX) | 0.1 | $1.3M | 1.4M | 0.93 | |
| Atara Biotherapeutics Com New (ATRA) | 0.1 | $1.0M | 125k | 8.13 | |
| Tenax Therapeutics Com New (TENX) | 0.0 | $288k | 83k | 3.46 |